Sameer Sheth

Co-founder of Motif Neurotech, a Houston-based therapeutic brain-computer interface company developing the Motif XCS System for treatment-resistant depression. A neurosurgeon and neuroscientist specializing in movement disorders, epilepsy, and psychiatric neurosurgery, he earned his MD and PhD through UCLA's Medical Scientist Training Program and completed his neurosurgical residency at Massachusetts General Hospital and Harvard Medical School. He is also a professor of neurosurgery and directs the Gordon and Mary Cain Pediatric Neurology Research Laboratories.